U.S. Representative, District 4 from Alabama
WINRED
$45.4K
8 donations
ADERHOLT MAJORITY FUND
$28.9K
3 donations
TRADITIONS BANK
$20.0K
2 donations
VULCAN MATERIALS CO. P. A. C.
$10.0K
2 donations
AMERICAN CRYSTAL SUGAR P. A. C.
$10.0K
2 donations
MTSI LEADERS FOR ENDURING SOLUTIONS
$10.0K
2 donations
REGIONS FINANCIAL CORPORATION POLITICAL ACTION COM
$10.0K
2 donations
AMERICAN ISRAEL PUBLIC AFFAIRS COMMITTEE PAC
$10.0K
2 donations
PROTECTIVE LIFE CORP P. A. C.
$10.0K
2 donations
DRUMMOND COMPANY, INC. PAC (DPAC)
$10.0K
2 donations
IERUS TECHNOLOGIES
via AGM CONSULTING SERVICES, INC.
$22.5K
2024Q4
MONTE SANO RESEARCH
via AGM CONSULTING SERVICES, INC.
$22.5K
2025Q2
TRIDEUM CORPORATION
via AGM CONSULTING SERVICES, INC.
$22.5K
2024Q4
ALLIANCE FOR RETIRED AMERICANS
via ALLIANCE FOR RETIRED AMERICANS
$90.0K
2024Q2
TRIDEUM CORP
via ATLANTIC STRATEGIES GROUP LLC
$10.0K
2024Q2
HUNT CONSOLIDATED INC.
via BROWNSTEIN HYATT FARBER SCHRECK, LLP
$30.0K
2025Q1
SELF-INSURANCE INSTITUTE OF AMERICA, INC.
via CALMETTO MANAGEMENT GROUP
$20.0K
2024Q1
SELF-INSURANCE INSTITUTE OF AMERICA, INC.
via CC LAW & POLICY
--
2024Q1
CENTER FOR RESPONSIBLE LENDING A SUPPORTING CORP OF CTR FOR COMMUNITY SELF-HELP
via CENTER FOR RESPONSIBLE LENDING, A SUPPORTING CORP OF CTR FOR COMMUNITY SELF-HELP
$89.0K
2024Q2
GSK
via CHECKMATE GOVERNMENT RELATIONS
$50.0K
2025Q2
Robert Aderholt (PEP) (COUNTER-SANCTIONED) Score: 100% Datasets: wd_peps, ann_pe...
Name matches are not proof of wrongdoing. Cross-references are provided for transparency and further investigation.
Stock trades matched to votes on bills affecting the same industry, within a 90-day window. Trades before a vote may suggest advance knowledge of legislative outcomes.
| Ticker | Trade | Trade Date | Bill | Vote | Vote Date | Gap |
|---|---|---|---|---|---|---|
| GSK | Sell | Jul 28, 2025 | SUPPORT for Patients and Communities Reauthorization Act of 2025 | nay | Jun 4, 2025 | 54d after |
| GSK | Sell | Jul 28, 2025 | SUPPORT for Patients and Communities Reauthorization Act of 2025 | yea | Jun 4, 2025 | 54d after |
| GSK | Sell | Jul 28, 2025 | SUPPORT for Patients and Communities Reauthorization Act of 2025 | nay | Jun 4, 2025 | 54d after |
| GSK | Sell | Jul 28, 2025 | SUPPORT for Patients and Communities Reauthorization Act of 2025 | yea | Jun 4, 2025 | 54d after |
| Date | Question | Bill | Position | Result |
|---|---|---|---|---|
| Apr 17, 2026 | On Agreeing to the Resolution | hres-119-1175 | yea | Failed |
| Apr 17, 2026 | On Agreeing to the Amendment | hres-119-1175 | yea | Failed |
| Apr 17, 2026 | On Ordering the Previous Question | hres-119-1175 | yea | Passed |
| Apr 16, 2026 | On Agreeing to the Resolution | hres-119-1156 | yea | Passed |
| Apr 16, 2026 | On Passage | hr-119-1689 | nay | Passed |
| Apr 16, 2026 | On Agreeing to the Resolution | hres-119-965 | nay | Passed |
| Apr 16, 2026 | On Passage | hr-119-6398 | yea | Passed |
| Apr 16, 2026 | On Motion to Recommit | hr-119-6398 | nay | Failed |
| Apr 16, 2026 | On Passage | hr-119-6409 | yea | Passed |
| Apr 16, 2026 | On Motion to Recommit | hr-119-6409 | nay | Failed |
| Apr 16, 2026 | On Agreeing to the Resolution | hconres-119-40 | nay | Failed |
| Apr 15, 2026 | On Motion to Discharge | hres-119-965 | nay | Passed |
| Apr 15, 2026 | On Agreeing to the Resolution | hres-119-1174 | yea | Passed |
| Apr 15, 2026 | On Ordering the Previous Question | hres-119-1174 | yea | Passed |
| Apr 14, 2026 | On Motion to Suspend the Rules and Pass, as Amended | hr-119-7613 | yea | Passed |
| Apr 14, 2026 | On Motion to Suspend the Rules and Pass | hr-119-1011 | yea | Passed |
| Mar 27, 2026 | On Agreeing to the Resolution | hres-119-1142 | yea | Passed |
| Mar 27, 2026 | On Ordering the Previous Question | hres-119-1142 | yea | Passed |
| Mar 27, 2026 | On Motion to Adjourn | -- | yea | Passed |
| Mar 27, 2026 | On Passage | hr-119-7084 | yea | Passed |